1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Auxly Cannabis Group Inc.
  6. Summary
    XLY   CA05335P1099

AUXLY CANNABIS GROUP INC.

(XLY)
  Report
Delayed Toronto Stock Exchange  -  03:59 2022-06-30 pm EDT
0.0750 CAD   +7.14%
06/30Auxly announces results of annual general meeting of shareholders
PR
06/30TRANSCRIPT : Auxly Cannabis Group Inc. - Shareholder/Analyst Call
CI
06/24Auxly Cannabis Extends Standby Facility Convertible Debentures to August 15, 2024
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/24/2022 06/27/2022 06/28/2022 06/29/2022 06/30/2022 Date
0.095(c) 0.09(c) 0.085(c) 0.07(c) 0.075(c) Last
1 043 968 799 042 754 847 2 092 879 545 372 Volume
0.00% -5.26% -5.56% -17.65% +7.14% Change
More quotes
Estimated financial data (e)
Sales 2022 114 M 88,6 M 88,6 M
Net income 2022 -60,1 M -46,5 M -46,5 M
Net Debt 2022 187 M 145 M 145 M
P/E ratio 2022 -0,90x
Yield 2022 -
Sales 2023 166 M 128 M 128 M
Net income 2023 -15,9 M -12,3 M -12,3 M
Net Debt 2023 218 M 169 M 169 M
P/E ratio 2023 -2,81x
Yield 2023 -
Capitalization 67,4 M 52,2 M 52,2 M
EV / Sales 2022 2,22x
EV / Sales 2023 1,72x
Nbr of Employees 558
Free-Float 78,6%
More Financials
Company
Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products for wellness and recreational consumers. The Company's segments include Canadian cannabis operations and South American cannabis operations. Both segments are engaged in the cultivation and sale of cannabis products... 
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
Ratings of Auxly Cannabis Group Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about AUXLY CANNABIS GROUP INC.
06/30Auxly announces results of annual general meeting of shareholders
PR
06/30TRANSCRIPT : Auxly Cannabis Group Inc. - Shareholder/Analyst Call
CI
06/24Auxly Cannabis Extends Standby Facility Convertible Debentures to August 15, 2024
AQ
06/23AUXLY CANNABIS GROUP BRIEF : Extending Standby Facility Convertible Debentures to August 1..
MT
06/23Auxly Extends Standby Facility Convertible Debentures to August 15, 2024
PR
06/06Auxly announces annual general meeting of shareholders
AQ
06/02Auxly Named Licensed Producer of the Year
PR
05/16TRANSCRIPT : Auxly Cannabis Group Inc., Q1 2022 Earnings Call, May 16, 2022
CI
05/16Auxly Cannabis Group Reports Wider Q1 Loss, Higher Revenue
MT
05/16AUXLY CANNABIS GROUP BRIEF : Cites Loss of $29.4 Million Relative to Same Period in 2021 P..
MT
05/16AUXLY CANNABIS GROUP BRIEF : Net Loss From Continuing Op $39.846 Million Representing a Ne..
MT
05/16AUXLY CANNABIS GROUP BRIEF : Details 47% Increase in Net Sales Vs Q1 in 2021, Recorded Net..
MT
05/16Auxly Cannabis Group Inc. Reports Impairment Changes for the First Quarter Ended March ..
CI
05/16Auxly Cannabis Group Inc. Reports Earnings Results for the First Quarter Ended March 31..
CI
05/10Auxly to report first quarter 2022 financial results on may 16, 2022
AQ
More news
News in other languages on AUXLY CANNABIS GROUP INC.
05/16Auxly Cannabis Group annonce une perte plus importante au premier trimestre, mais une h..
05/16Auxly Cannabis Group Inc. annonce ses résultats pour le premier trimestre clos le 31 ma..
04/20Lotus Ventures Inc. annonce le deuxième lancement officiel d'une souche en collaboratio..
04/07Les contrats à terme du TSX sont en hausse alors que le pétrole augmente avant le budge..
03/31Auxly Cannabis Group Inc. annonce ses résultats pour l'exercice complet terminé le 31 d..
More news
Chart AUXLY CANNABIS GROUP INC.
Duration : Period :
Auxly Cannabis Group Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AUXLY CANNABIS GROUP INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,08 CAD
Average target price 0,33 CAD
Spread / Average Target 333%
EPS Revisions
Managers and Directors
Hugo M. Alves Director
Michael Lickver President
Brian Schmitt Chief Financial Officer
Genevieve Young Chairman
Troy James Grant Independent Director